Evidence map›Paper›PMID 32382998›Full record

ReviewHigh blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension2020

Multidisciplinary Consensus Document on the Management of Uncontrolled Hypertension in India.

R Padmanabhan, Rana Gopal Singh, Govindan Unni, Bhupen Desai, Sanjeev Kumar Hiremath, Vidyut Jain, Saikat Bhawal, Sanjeev Gulati, Mukesh Shete, Ramesh Nair and 3 more

Abstract readReviewConsensus Statement
PubMed Publisher
In one paragraph

Review in High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 8 institutions in 1 country.

R PadmanabhanDepartment of Nephrology, SRM Medical College and Hospital, Chennai, Tamil Nadu, India. rustaqdr@yahoo.co.in.
Rana Gopal SinghDepartment of Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India.
Govindan UnniDepartment of Cardiology, Jubilee Mission Medical College and Research Institute, Thrissur, Kerala, India.
Bhupen DesaiDepartment of Cardiology, Karuna Hospital, Borivali West, Mumbai, Maharashtra, India.
Sanjeev Kumar HiremathDepartment of Nephrology, Sagar Hospitals, Bangalore, Karnataka, India.
Vidyut JainDepartment of Cardiology, Choithram Hospital and Research Center, Indore, India.
Saikat BhawalConsultant Physician and Diabetologist, Ashok Nursing Home Private Limited, Kolkata, West Bengal, India.
Sanjeev GulatiDepartment of Nephrology, Fortis Hospitals, New Delhi, India.
Mukesh SheteDepartment of Nephrology, Apex Kidney Care, Mumbai, Maharashtra, India.
Ramesh NairDepartment of Medicine, Lakshmi Hospital, Diwans Road, Ernakulam, Kerala, India.
Sunil PrakashDepartment of Nephrology, BLK Super Specialty Hospital, New Delhi, India.
Vijay KherChairman, Department of Nephrology, Medanta Kidney and Urology Institute, Haryana, India.
Bijan BhattacharyaDepartment of Nephrology, Ruby General Hospital, Kolkata, West Bengal, India.
Banaras Hindu University · INBLK Super Speciality Hospital · INChoithram Hospital and Research Centre · INFortis Hospital · INGeneral Hospital Ernakulam · INJubilee Mission Medical College and Research Institute · INMedanta The Medicity · INMedical College and Hospital, Kolkata · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cardiovascular disease is predicted to be the largest cause of death and disability in India by 2020. Hypertension (HT), one of the main contributing factors, presents a significant public health burden. Inability to achieve adequate blood pressure (BP) control results in uncontrolled hypertension (UHT). The prevalence of UHT is high in India, with only about 9-20% of patients achieving target BP goals. Presently, there are no guidelines specific to UHT, which if left uncontrolled can lead to resistant HT, chronic kidney disease and other complications of HT. A multidisciplinary panel, comprising of specialists in cardiology, nephrology and internal medicine, was convened to address the diagnosis and management of UHT in the Indian population. The panel identified key points concerning UHT and discussed management recommendations in the Indian clinical setting.

Indexed as

Risk Reduction BehaviorAlgorithmsAntihypertensive AgentsBlood PressureClinical Decision-MakingComorbidityDecision Support TechniquesDisease ProgressionDrug ResistanceHumansHypertensionIndiaPrevalenceRisk FactorsTreatment OutcomeAntihypertensive AgentsBlood pressureCardiologyCardiovascular diseasesHypertensionIndiaRenal insufficiency

Identifiers

PMID32382998
OpenAlexW3022120347

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.